Page last updated: 2024-11-04

sumatriptan and Brain Infarction

sumatriptan has been researched along with Brain Infarction in 1 studies

Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.

Brain Infarction: Tissue NECROSIS in any area of the brain, including the CEREBRAL HEMISPHERES, the CEREBELLUM, and the BRAIN STEM. Brain infarction is the result of a cascade of events initiated by inadequate blood flow through the brain that is followed by HYPOXIA and HYPOGLYCEMIA in brain tissue. Damage may be temporary, permanent, selective or pan-necrosis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pradalier, A1
Lutz, G1
Vincent, D1

Other Studies

1 other study available for sumatriptan and Brain Infarction

ArticleYear
Transient global amnesia, migraine, thalamic infarct, dihydroergotamine, and sumatriptan.
    Headache, 2000, Volume: 40, Issue:4

    Topics: Amnesia, Transient Global; Brain Infarction; Dihydroergotamine; Female; Humans; Injections, Subcutan

2000